The primary goal of this Training Program is to prepare Predoctoral and Postdoctoral Fellows for investigative careers in Cancer Research. The Predoctoral Training Program provides a forum within the current Biomedical Sciences Training Program for graduate training at CWRU that emphasizes Cancer Research. Trainees will have intensive research experience under the close guidance of a full-time faculty member in the disciplines of Pharmacology, Molecular Biology, Biochemistry, Physiology and Biophysics, Immunology or Cell Biology. The Postdoctoral Training Program integrates the training of basic scientists (PhD) and physician scientists (M.D. or M.D./Ph.D.) under the direction of a select faculty from the Comprehensive Cancer Center at Case Western Reserve University and University Hospitals of Cleveland who bridge traditional departmental boundaries to apply multidisciplinary approaches to fundamental problems in oncology. For Postdoctoral Trainees, formal didactic training will include required participation in a scientific ethics course, """"""""On Being a Professional Scientist: Ethics and Biomedical Research"""""""", the weekly Cancer Center Seminar series, and the weekly Cancer Biology and Cancer Genetics Journal Club. Both predoctoral and postdoctoral trainees make formal presentations of their research at two interdisciplinary Cancer Center sponsored events: the monthly Cancer Training Meeting and the annual Cancer Center Retreat. All Trainees will be expected to attend formal basic science seminars relevant to their area of study. M.D. Postdoctoral Trainees, without previous research training, will be encouraged to attend graduate level basic science courses as needed to bring their level of knowledge up to that of Ph.D. or M.D./Ph.D. trainees. Predoctoral Trainees will participate in the Core Academic Program of the Biomedical Sciences Training Program within the first semester of training, then in the remaining period of training participate in thesis research with a Research Oncology Training Program faculty mentor, with additional didactic course work focused on cancer. The Training Program will be governed by a Steering Committee charged with responsibility for (i) active recruitment of trainees, with an emphasis on women and underrepresented minorities; (ii) selection of high caliber candidates who are fully committed to Cancer Research careers; (iii) tracking the progress of trainees according to specified criteria and standards; (iv) evaluating the mentorship provided by individual faculty; and (v) tracking the success of trainees who have completed the training program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA059366-13
Application #
7123826
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1993-06-01
Project End
2009-09-29
Budget Start
2006-09-30
Budget End
2007-09-29
Support Year
13
Fiscal Year
2006
Total Cost
$362,277
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Barker, Emily C; Kim, Byung-Gyu; Yoon, Ji Hee et al. (2018) Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation. Carcinogenesis 39:36-46
Reinartz, Roman; Wang, Shanshan; Kebir, Sied et al. (2017) Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma. Clin Cancer Res 23:562-574
Samaeekia, Ravand; Adorno-Cruz, Valery; Bockhorn, Jessica et al. (2017) miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway. Clin Cancer Res 23:1091-1103
Sahni, Jennifer M; Gayle, Sylvia S; Webb, Bryan M et al. (2017) Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors. Cancer Res 77:5395-5408
Seachrist, Darcie D; Sizemore, Steven T; Johnson, Emhonta et al. (2017) Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Breast Cancer Res 19:66
Zhao, Yiqing; Scott, Anthony; Zhang, Peng et al. (2017) Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis. Oncotarget 8:48782-48793
Bryson, Benjamin L; Junk, Damian J; Cipriano, Rocky et al. (2017) STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle 16:319-334
Gayle, Sylvia S; Sahni, Jennifer M; Keri, Ruth A (2017) BETi induction of mitotic catastrophe: towing the LIN9. Oncoscience 4:128-130
Junk, D J; Bryson, B L; Smigiel, J M et al. (2017) Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene 36:4001-4013
Doherty, Mary R; Smigiel, Jacob M; Junk, Damian J et al. (2016) Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers (Basel) 8:

Showing the most recent 10 out of 82 publications